Szu-Yi Chou
Overview
Explore the profile of Szu-Yi Chou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
513
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu R, Chan L, Chou S, Lin L, Hu C, Hong C
Age Ageing
. 2024 Nov;
53(11).
PMID: 39523602
Behavioural symptoms are common manifestations of Parkinson's disease (PD). Early behavioural symptoms characterise mild behavioural impairment (MBI). The prevalence and intensity of MBI in people with PD (PwP) have been...
2.
Ho M, Tsai Y, Chen C, Yang A, Burnouf T, Wang Y, et al.
J Biomed Sci
. 2024 Sep;
31(1):91.
PMID: 39285280
Background: Traumatic brain injury (TBI) causes axon tearing and synapse degradation, resulting in multiple neurological dysfunctions and exacerbation of early neurodegeneration; the repair of axonal and synaptic structures is critical...
3.
Delila L, Nebie O, Le N, Timmerman K, Lee D, Wu Y, et al.
J Biomed Sci
. 2024 Sep;
31(1):87.
PMID: 39237980
Background: The burgeoning field of regenerative medicine has significantly advanced with recent findings on biotherapies using human platelet lysates (HPLs), derived from clinical-grade platelet concentrates (PCs), for treating brain disorders....
4.
Chou S, Bamodu O, Chiu W, Hong C, Chan L, Chung C
Sci Rep
. 2022 May;
12(1):7254.
PMID: 35508580
Existing prognostic models to predict the neurological recovery in patients with cardiac arrest receiving targeted temperature management (TTM) either exhibit moderate accuracy or are too complicated for clinical application. This...
5.
Chiang I, Liu Y, Liu H, Ali A, Chou S, Hsu T, et al.
Neurotherapeutics
. 2022 Mar;
19(2):616-634.
PMID: 35267171
Temozolomide (TMZ) monotherapy is known to be insufficient for resistant/relapsed glioblastoma (GBM), thus seeking a sensitization agent for TMZ is necessary. It was found that regorafenib may improve the overall...
6.
Nyam-Erdene A, Nebie O, Delila L, Buee L, Devos D, Chou S, et al.
ACS Biomater Sci Eng
. 2021 Nov;
7(12):5823-5835.
PMID: 34846835
Human platelet lysates (HPLs) made from clinical-grade platelet concentrates are currently evaluated in the preclinical models of Parkinson's disease, Alzheimer's disease, traumatic brain injury, and others, as a new polyvalent...
7.
Ho M, Yen C, Hsieh T, Kao T, Chiu J, Chiang Y, et al.
Redox Biol
. 2021 Jul;
46:102067.
PMID: 34315111
Traumatic brain injury (TBI) is a prevalent head injury worldwide which increases the risk of neurodegenerative diseases. Increased reactive oxygen species (ROS) and inflammatory chemokines after TBI induces secondary effects...
8.
Nebie O, Carvalho K, Barro L, Delila L, Faivre E, Renn T, et al.
Brain
. 2021 Jun;
144(10):3142-3158.
PMID: 34086871
Traumatic brain injury (TBI) leads to major brain anatomopathological damages underlined by neuroinflammation, oxidative stress and progressive neurodegeneration, ultimately leading to motor and cognitive deterioration. The multiple pathological events resulting...
9.
Ajoy R, Lo Y, Ho M, Chen Y, Wang Y, Chen Y, et al.
Mol Psychiatry
. 2021 May;
26(11):6451-6468.
PMID: 33931731
Glucoregulatory efficiency and ATP production are key regulators for neuronal plasticity and memory formation. Besides its chemotactic and neuroinflammatory functions, the CC chemokine--CCL5 displays neurotrophic activity. We found impaired learning-memory...
10.
Chou S, Chan L, Chung C, Chiu J, Hsieh Y, Hong C
Front Cell Dev Biol
. 2020 Dec;
8:564641.
PMID: 33344443
Introduction: Diabetes increases the risk of Parkinson's disease (PD). The phosphorylation of type 1 insulin receptor substrate (IRS-1) determines the function of insulin signaling pathway. Extracellular vesicles (EVs) are emerging...